Measurement of toxin production by Clostridium difficile [4]

Lancet

Volumn 367, Issue 9515, 2006, Pages 982-983

  Freeman, Jane ^a   Fawley, Warren ^a   Baines, Simon ^a   Wilcox, Mark ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN;

BACTERIAL INFECTION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM CULTURE; BACTERIUM DETECTION; CLOSTRIDIUM DIFFICILE; DISEASE SEVERITY; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LETTER; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPECTROPHOTOMETRY; STRAIN DIFFERENCE; TOXIN SYNTHESIS;

EID: 33645099743     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68417-1     Document Type: Letter

References (5)

1. M Warny, J Pepin, A Fang Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Lancet 36 2005 1079 1084
2. B Dupuy, AL Sonnenshein Regulated transcription of Clostridium difficile toxin genes Mol Microbiol 27 1998 107 120
3. MC Barc, C Depitre, G Corthier, A Collignon, Su WJ, Bourlioux P Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo Antimicrob Agents Chemother 36 1992 1332 1335
4. J Freeman, SD Baines, D Jabes, MH Wilcox Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection J Antimicrob Chemother 56 2005 717 725
5. J Pepin, L Valiquette, ME Alary Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity CMAJ 171 2004 466 472